145 related articles for article (PubMed ID: 20067918)
1. Myocardial infarction and other major vascular events during chemotherapy for testicular cancer.
Dieckmann KP; Gerl A; Witt J; Hartmann JT;
Ann Oncol; 2010 Aug; 21(8):1607-1611. PubMed ID: 20067918
[TBL] [Abstract][Full Text] [Related]
2. Vascular toxicity associated with chemotherapy for testicular cancer.
Gerl A
Anticancer Drugs; 1994 Dec; 5(6):607-14. PubMed ID: 7534146
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk in testicular cancer survivors treated with chemotherapy: incidence, significance, and practice implications.
Zoltick BH; Jacobs LA; Vaughn DJ
Oncol Nurs Forum; 2005 Sep; 32(5):1005-9; quiz 1010-1. PubMed ID: 16136198
[TBL] [Abstract][Full Text] [Related]
4. Sexual function in men treated for testicular cancer.
Eberhard J; Ståhl O; Cohn-Cedermark G; Cavallin-Ståhl E; Giwercman Y; Rylander L; Eberhard-Gran M; Kvist U; Fugl-Meyer KS; Giwercman A
J Sex Med; 2009 Jul; 6(7):1979-89. PubMed ID: 19453896
[TBL] [Abstract][Full Text] [Related]
5. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; Nuver J; de Wit R; Gietema JA; ten Bokkel Huinink WW; Rodrigus PT; Schimmel EC; Aleman BM; van Leeuwen FE
J Clin Oncol; 2006 Jan; 24(3):467-75. PubMed ID: 16421423
[TBL] [Abstract][Full Text] [Related]
6. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
[TBL] [Abstract][Full Text] [Related]
7. Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012.
Quiros-Roldan E; Raffetti E; Focà E; Brianese N; Ferraresi A; Paraninfo G; Pezzoli MC; Bonito A; Magoni M; Scarcella C; Castelli F
AIDS Care; 2016 Dec; 28(12):1551-1558. PubMed ID: 27321070
[TBL] [Abstract][Full Text] [Related]
8. Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols.
Tandstad T; Solberg A; Håkansson U; Stahl O; Haugnes HS; Oldenburg J; Dahl O; Kjellman A; Angelsen A; Cohn-Cedermark G;
Acta Oncol; 2015 Apr; 54(4):493-9. PubMed ID: 25192551
[TBL] [Abstract][Full Text] [Related]
9. Long-term complications of chemotherapy for germ cell tumours.
Chaudhary UB; Haldas JR
Drugs; 2003; 63(15):1565-77. PubMed ID: 12887263
[TBL] [Abstract][Full Text] [Related]
10. [Early myocardial infarction associated with chemotherapy for testicular cancer].
Bernard P; Cellarier G; Crémades S; Gisserot O; De Jauréguiberry JP
Rev Med Interne; 2006 Jun; 27(6):497-8. PubMed ID: 16546304
[TBL] [Abstract][Full Text] [Related]
11. [Acute myocardial infarct following chemotherapy for testicular carcinoma: on the coronary toxicity of cytostatic agents].
Borek G; Gebel F; Jenzer HR
Schweiz Med Wochenschr; 1991 Mar; 121(11):385-9. PubMed ID: 1851325
[TBL] [Abstract][Full Text] [Related]
12. [Cerebral infarction and myocardial infarction due to cisplatin-containing chemotherapy].
Brouha ME; Bloemendal HJ; Kappelle LJ; Winter JB
Ned Tijdschr Geneeskd; 2003 Mar; 147(10):457-60. PubMed ID: 12666519
[TBL] [Abstract][Full Text] [Related]
13. Late complications of chemotherapy in testicular cancer.
Pliarchopoulou K; Pectasides D
Cancer Treat Rev; 2010 May; 36(3):262-7. PubMed ID: 20092952
[TBL] [Abstract][Full Text] [Related]
14. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.
Berger CC; Bokemeyer C; Schneider M; Kuczyk MA; Schmoll HJ
Eur J Cancer; 1995 Dec; 31A(13-14):2229-38. PubMed ID: 8652248
[TBL] [Abstract][Full Text] [Related]
15. Arterial occlusive events during chemotherapy for germ cell cancer.
Vos AH; Splinter TA; van der Heul C
Neth J Med; 2001 Dec; 59(6):295-9. PubMed ID: 11744182
[TBL] [Abstract][Full Text] [Related]
16. No evidence of acute cardiovascular complications of chemotherapy for testicular cancer: an analysis of the Testicular Cancer Intergroup Study.
Nichols CR; Roth BJ; Williams SD; Gill I; Muggia FM; Stablein DM; Weiss RB; Einhorn LH
J Clin Oncol; 1992 May; 10(5):760-5. PubMed ID: 1285740
[TBL] [Abstract][Full Text] [Related]
17. Predictors of thrombosis in testicular cancer during platinum-based chemotherapy.
Paffenholz P; Grein K; Heidegger I; Nestler T; Grabbert M; Salem J; Hellmich M; Pfister D; Heidenreich A
World J Urol; 2019 Sep; 37(9):1907-1916. PubMed ID: 30547197
[TBL] [Abstract][Full Text] [Related]
18. Testicular cancer risk according to county of birth and county of diagnosis in Norway, 1958-2007.
Kvammen O; Tretli S; Johannessen TB; Klepp O; Grotmol T
Acta Oncol; 2012 Feb; 51(2):177-84. PubMed ID: 22248063
[TBL] [Abstract][Full Text] [Related]
19. [Pre- and paraclinical cooperative trials on testicular cancer. Background and overview of current trials].
Dieckmann KP
Urologe A; 2007 Sep; 46(9):1180-4. PubMed ID: 17594070
[TBL] [Abstract][Full Text] [Related]
20. Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis.
Doll DC; List AF; Greco FA; Hainsworth JD; Hande KR; Johnson DH
Ann Intern Med; 1986 Jul; 105(1):48-51. PubMed ID: 2424354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
